Ibex Obtains CE Mark for Galen Gastric, the World’s First AI-powered Solution for Gastric Cancer Detection (PR Newswire)

TEL AVIV, Israel, June 15, 2022 /PRNewswire/ — Ibex Medical Analytics, the pioneer in AI-powered cancer diagnostics, today announced CE mark for the Galen™ Gastric solution that supports pathologists in the detection of various types of gastric cancer. With this first-of-its-kind solution becoming generally available, Ibex offers the richest portfolio of artificial intelligence (AI) solutions in pathology, enabling detection of cancer and other pathologies in gastric, breast and prostate biopsies.